Leerink Partners Remains a Hold on DENTSPLY SIRONA (XRAY)

In a report released on October 14, Michael Cherny from Leerink Partners maintained a Hold rating on DENTSPLY SIRONA, with a price target of $13.50. The company’s shares closed yesterday at $12.80.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Cherny covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, McKesson, and Align Tech. According to TipRanks, Cherny has an average return of 5.1% and a 56.80% success rate on recommended stocks.

The word on The Street in general, suggests a Hold analyst consensus rating for DENTSPLY SIRONA with a $15.57 average price target, which is a 21.64% upside from current levels. In a report released on October 13, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $11.50 price target.

Based on DENTSPLY SIRONA’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $936 million and a GAAP net loss of $45 million. In comparison, last year the company earned a revenue of $984 million and had a GAAP net loss of $4 million